IP Verse

Agios Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Sep 13, 2023

Title:

Methods Of Using Pyruvate Kinase Activators

Oppositions:

Patent:

Grant Date:

Aug 2, 2023

Title:

Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3307271	Sep 13, 2023	Methods Of Using Pyruvate Kinase Activators	2
EP3713919	Aug 2, 2023	Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide	2

BOTTI & FERRARI S.P.A.

SANDOZ AG

Feel free to send us a message here and we will get back to you